Albemarle Corporation's Chief People Officer, Autumn M. Gagarinas, reported an acquisition of restricted stock units in a statement of changes in beneficial ownership filed with the SEC on September 16, 2026, reflecting a transaction dated September 14, 2026.
Key Highlights
- Reporting person: Autumn M. Gagarinas, identified as Chief People Officer of Albemarle Corporation (NYSE:ALB).
- Shares acquired: 5,217 shares of Common Stock were acquired at a price of $0, coded as an acquisition (A).
- Award type: The acquired shares are Restricted Stock Units, per the filing's explanation of responses.
- Vesting schedule: The RSUs vest 50% on 03/14/2028 and 50% on 09/14/2029, subject to the terms of the award agreement.
- Resulting ownership: Following the transaction, Gagarinas directly beneficially owns 10,610 shares of Common Stock.
- Filed by: The form was signed by Corey E. Tanner as attorney-in-fact on September 16, 2026.
Albemarle RSU Award Details for Chief People Officer Gagarinas
According to the filing, Autumn M. Gagarinas, who serves as Chief People Officer of Albemarle Corporation, a specialty chemicals company listed on the New York Stock Exchange under the ticker ALB, received a grant of 5,217 restricted stock units on September 14, 2026. The transaction was recorded with an acquisition code and a price of $0, consistent with an equity award rather than a market purchase. The filing notes no derivative securities were involved in the reported transaction.
The filing discloses that the RSUs are subject to a two-tranche vesting schedule: 50% of the units are set to vest on March 14, 2028, and the remaining 50% on September 14, 2029, each tranche contingent on the terms of the underlying award agreement. Following the acquisition of these units, Gagarinas's total directly held beneficial ownership of Albemarle Common Stock stood at 10,610 shares, as reported in Table I of the filing. No indirect ownership was reported for this transaction.
What Was Disclosed
The filing reports a September 14, 2026 grant of 5,217 restricted stock units to Albemarle's Chief People Officer at no cost, with a split vesting schedule across 2028 and 2029, bringing her total direct beneficial ownership to 10,610 shares of Common Stock.




Please wait processing your request...